1Wiman B, Andersson T, Hallqvist J, et al . Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and yon Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study[J]. Arterioscler Thromb Vasc Biol ,2000,20(8) :2019-2023. 被引量：1
2Blann AD,Lip GYH,Beevers DG, et al . Soluble P-seclectin in atherosclerosis:A comparison with endothelial cell and platelet markers[J]. Thromb Haemost , 1997,77 : 1077-1083. 被引量：1
3Blann AD. Soluble P-seleetin in atheroselerosis: A comparison with endothelial cell and platelet markers [J]. Thromb Haemost , 1997, 77: 1077-1082. 被引量：1
4Furie B,Furie PC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes : Role of Pselection and the P-selectin ligand, PSGL-1[J]. Thromb Haomost , 1995 ; 74 : 224. 被引量：1
5Denis CC, Andre P, Saflaripour S, et al . Defect in regulated secretion of P-selectin affects leukocyent in yon Willebrand Factor-deficient mice[J]. Proc Natl Acad Sci USA ,2001, 98 (7):4072-4077. 被引量：1
